Functional and Molecular Effects of Mercury Compounds on the Human OCTN1 Cation Transporter: C50 and C136 Are the Targets for Potent Inhibition
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional and Molecular Effects of Mercury Compounds on the Human OCTN1 Cation Transporter: C50 and C136 Are the Targets for Potent Inhibition
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 144, Issue 1, Pages 105-113
Publisher
Oxford University Press (OUP)
Online
2014-12-10
DOI
10.1093/toxsci/kfu259
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling
- (2014) Lorena Pochini et al. BIOCHEMICAL PHARMACOLOGY
- Crystal structure of the human glucose transporter GLUT1
- (2014) Dong Deng et al. NATURE
- Glutathione controls the redox state of the mitochondrial carnitine/acylcarnitine carrier Cys residues by glutathionylation
- (2013) Nicola Giangregorio et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury
- (2013) José G. Dórea et al. JOURNAL OF APPLIED TOXICOLOGY
- FAD Synthesis and Degradation in the Nucleus Create a Local Flavin Cofactor Pool
- (2013) Teresa Anna Giancaspero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selenoneine, a Novel Selenium-Containing Compound, Mediates Detoxification Mechanisms against Methylmercury Accumulation and Toxicity in Zebrafish Embryo
- (2013) Michiaki Yamashita et al. MARINE BIOTECHNOLOGY
- Functional Analysis of Novel Variants in the Organic Cation/Ergothioneine Transporter 1 Identified in Singapore Populations
- (2013) Dorothy Su Lin Toh et al. MOLECULAR PHARMACEUTICS
- Crystal structure of a eukaryotic phosphate transporter
- (2013) Bjørn P. Pedersen et al. NATURE
- Molecular Mechanism of Inhibition of the Mitochondrial Carnitine/Acylcarnitine Transporter by Omeprazole Revealed by Proteoliposome Assay, Mutagenesis and Bioinformatics
- (2013) Annamaria Tonazzi et al. PLoS One
- Proteoliposomes as Tool for Assaying Membrane Transporter Functions and Interactions with Xenobiotics
- (2013) Mariafrancesca Scalise et al. Pharmaceutics
- Over-expression in Escherichia coli, purification and reconstitution in liposomes of the third member of the OCTN sub-family: The mouse carnitine transporter OCTN3
- (2012) Mariafrancesca Scalise et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Three-Dimensional Structures of Membrane Proteins from Genomic Sequencing
- (2012) Thomas A. Hopf et al. CELL
- Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system
- (2012) Lorena Pochini et al. LIFE SCIENCES
- Strategies of Bacterial Over Expression of Membrane Transporters Relevant in Human Health: The Successful Case of the Three Members of OCTN Subfamily
- (2012) Cesare Indiveri et al. MOLECULAR BIOTECHNOLOGY
- Inhibition of the OCTN2 carnitine transporter by HgCl2and methylmercury in the proteoliposome experimental model: insights in the mechanism of toxicity
- (2012) Lorena Pochini et al. TOXICOLOGY MECHANISMS AND METHODS
- Reconstitution in liposomes of the functionally active human OCTN1 (SLC22A4) transporter overexpressed inEscherichia coli
- (2011) Lorena Pochini et al. BIOCHEMICAL JOURNAL
- The B°AT1 amino acid transporter from rat kidney reconstituted in liposomes: Kinetics and inactivation by methylmercury
- (2011) Francesca Oppedisano et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn's disease
- (2011) Lorena Pochini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Effects of heavy metal cations on the mitochondrial ornithine/citrulline transporter reconstituted in liposomes
- (2011) Annamaria Tonazzi et al. BIOMETALS
- Acetylcholine as an age-dependent non-neuronal source in the heart
- (2010) Obaida R. Rana et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- Inactivation by Hg 2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling
- (2010) Francesca Oppedisano et al. BIOCHEMICAL PHARMACOLOGY
- Mercury induces inflammatory mediator release from human mast cells
- (2010) Duraisamy Kempuraj et al. Journal of Neuroinflammation
- Transport of Inorganic Mercury and Methylmercury in Target Tissues and Organs
- (2010) Christy C. Bridges et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Gene Knockout and Metabolome Analysis of Carnitine/Organic Cation Transporter OCTN1
- (2010) Yukio Kato et al. PHARMACEUTICAL RESEARCH
- Protein structure prediction on the Web: a case study using the Phyre server
- (2009) Lawrence A Kelley et al. Nature Protocols
- Over-expression in E. coli and purification of the human OCTN1 transport protein
- (2009) Michele Galluccio et al. PROTEIN EXPRESSION AND PURIFICATION
- Functional Characterization of Ergothioneine Transport by Rat Organic Cation/Carnitine Transporter Octn1 (slc22a4)
- (2008) Toshimichi Nakamura et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
- (2008) I Wessler et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes
- (2008) Lorena Pochini et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Synthesis and characterization of carnitine nitro-derivatives
- (2007) Oriana Piermatti et al. BIOORGANIC & MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started